Pool-Zobel Beatrice Louise, Selvaraju Veeriah, Sauer Julia, Kautenburger Tanja, Kiefer Jeannette, Richter Konrad Klaus, Soom Malle, Wölfl Stefan
Department of Nutritional Toxicology, Institute for Nutrition, Friedrich-Schiller-University, Dornburger Strasse 25, D-07743 Jena, Germany.
Carcinogenesis. 2005 Jun;26(6):1064-76. doi: 10.1093/carcin/bgi059. Epub 2005 Mar 3.
Butyrate, formed by bacterial fermentation of plant foods, has been suggested to reduce colon cancer risks by suppressing the proliferation of tumor cells. In addition, butyrate has been shown to induce glutathione S-transferases (GSTs) in tumor cell lines, which may contribute to the detoxification of dietary carcinogens. We hypothesize that butyrate also affects biotransformation in non-transformed colon cells. Thus, we have investigated the gene expression of drug metabolism genes in primary human colon tissue, premalignant LT97 adenoma and HT29 tumor cells cultured in an appropriate medium+/-butyrate. A total of 96 drug metabolism genes (including 12 GSTs) spotted on cDNA macroarrays (Superarray; n = 3) were hybridized with biotin-labeled cDNA probes. To validate the expression detected with Superarray, samples of LT97 cells were also analyzed with high density microarrays (Affymetrix U133A), which include biotransformation genes that overlap with the set of genes represented on the Superarray. Relative expression levels were compared across colon samples and for each colon sample+/-butyrate. Compared with fresh tissue, 13 genes were downregulated in primary cells cultivated ex vivo, whereas 8 genes were upregulated. Several genes were less expressed in LT97 (40 genes) or in HT29 (41 and 17 genes, grown for 72 and 48 h, respectively) compared with primary colon tissue. Butyrate induced GSTP1, GSTM2, and GSTA4 in HT29 as previously confirmed by other methods (northern blot/qPCR). We detected an upregulation of GSTs (GSTA2, GSTT2) that are known to be involved in the defence against oxidative stress in primary cells upon incubation with butyrate. The changes in expression detected in LT97 by Superarray and Affymetrix were similar, confirming the validity of the results. We conclude that low GST expression levels were favourably altered by butyrate. An induction of the toxicological defence system possibly contributes to reported chemopreventive properties of butyrate, a product of dietary fibre fermentation in the gut.
由植物性食物经细菌发酵形成的丁酸盐,被认为可通过抑制肿瘤细胞增殖来降低结肠癌风险。此外,丁酸盐已被证明可在肿瘤细胞系中诱导谷胱甘肽S-转移酶(GSTs),这可能有助于饮食致癌物的解毒。我们推测丁酸盐也会影响未转化结肠细胞中的生物转化。因此,我们研究了在合适培养基中培养的原代人结肠组织、癌前LT97腺瘤和HT29肿瘤细胞中药物代谢基因的基因表达,培养基中添加或不添加丁酸盐。将点在cDNA宏阵列(Superarray;n = 3)上的总共96个药物代谢基因(包括12个GSTs)与生物素标记的cDNA探针杂交。为了验证用Superarray检测到的表达,还使用高密度微阵列(Affymetrix U133A)分析了LT97细胞样本,该微阵列包括与Superarray上所代表的基因集重叠的生物转化基因。比较了不同结肠样本以及每个结肠样本添加或不添加丁酸盐时的相对表达水平。与新鲜组织相比,体外培养的原代细胞中有13个基因下调,而8个基因上调。与原代结肠组织相比,LT97(40个基因)或HT29(分别培养72小时和48小时的41个和17个基因)中有几个基因表达较少。如先前通过其他方法(Northern印迹/qPCR)所证实的,丁酸盐在HT29中诱导了GSTP1、GSTM2和GSTA4。我们检测到在原代细胞中与丁酸盐孵育后,已知参与抗氧化应激防御的GSTs(GSTA2、GSTT2)上调。Superarray和Affymetrix在LT97中检测到的表达变化相似,证实了结果的有效性。我们得出结论,丁酸盐有利地改变了低GST表达水平。毒理学防御系统的诱导可能有助于丁酸盐(肠道中膳食纤维发酵的产物)所报道的化学预防特性。